Connecting breath and mind for teenagers with long COVID
Connecting Breath and Mind: Development of an Online Holistic Treatment Programme Connecting Psychological Wellbeing and Breathing Techniques in Children and Young People With Long COVID
This study is testing a new program that helps teenagers with long COVID feel better mentally and breathe easier by using their ideas and creativity alongside regular treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 12 Years to 18 Years |
| Sex | All |
| Sponsor | Royal Brompton & Harefield NHS Foundation Trust Academic / other |
| Locations | 1 site (London, Chelsea) |
| Trial ID | NCT05705154 on ClinicalTrials.gov |
What this trial studies
This study aims to co-design and pilot an intervention for children and young people (CYP) aged 12-18 years suffering from long COVID, focusing on improving psychological wellbeing and reducing breathlessness. The intervention will be developed collaboratively with CYP, incorporating their feedback and emphasizing creativity and playfulness. In the pilot phase, 40 participants will be randomly assigned to receive the new intervention alongside standard treatment, with various assessments conducted to measure improvements in mental health and respiratory function. The study will utilize established questionnaires to evaluate outcomes pre- and post-intervention.
Who should consider this trial
Good fit: Ideal candidates are children and young people aged 12-18 years who have been referred to the pan-London long COVID multidisciplinary team.
Not a fit: Patients without objective evidence of SARS-CoV-2 infection or those with significant neurodevelopmental difficulties or high psychiatric risk may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the psychological and physical wellbeing of teenagers suffering from long COVID.
How similar studies have performed: While the approach of co-designing interventions with young patients is innovative, similar studies have shown promise in improving outcomes for chronic conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients aged 12-18 years referred to the pan-London long COVID MDT with English of a standard adequate to participate in a group intervention. Exclusion Criteria: * No objective evidence of SARS-CoV-2 infection e.g., positive PCR testing or antibodies. Significant neurodevelopmental difficulties (severe autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), global intellectual disability) and/or high psychiatric risk e.g., suicidality, severe emotional or behavioural dysregulation precluding participation in group intervention (PI screened during the MDT discussion and by lead researcher during telephone call for recruitment).
Where this trial is running
London, Chelsea
- The Royal Brompton Hospital part of Guys and St Thomas' NHS Foundation Trust — London, Chelsea, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Samatha Sonnappa, MD PhD
- Email: s.sonnappa@rbht.nhs.uk
- Phone: 02073528121
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.